克林霉素联合妇科千金片治疗慢性盆腔炎的临床效果及安全性分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the clinical efficacy and safety of Clindamycin combined with Gynecological Qianjin Tablets in the treatment of chronic pelvic inflammatory disease.MethodsFrom May 2015 to November 2016,162 cases of patients with chronic pelvic inflammatory disease who treated in our hospital were selected as subjects,and they were divided into single drug group and combined drug group according to different treatment methods,81 cases in each group.The single drug group was treated with Clindamycin,the combined drug group was treated with Clindamycin combined with Gynecological Qianjin Tablets.The scores of clinical symptoms,clinical efficacy and adverse reactions were compareed between the two groups.ResultsAfter treatment,the scores of lower abdominal pain,swelling,leucorrhea,leucorrhea and lassitude in the combined drug group were lower than those in the single drug group,the differences were statistically significant(P＜0.05).The total effective rate of the combined drug group(97.53%)was higher than that of the single drug group(87.65%),the difference was statistically significant(P＜0.05).The incidence of adverse reactions in the combined drug group(6.17%)was significantly lower than that in the single drug group(17.28%),the difference was statistically significant (P＜0.05).ConclusionClindamycin combined with Gynecological Qianjin Tablets in the treatment of chronic pelvic inflammatory disease can effectively relieve the clinical symptoms,improve the clinical efficacy,less adverse reactions,and have high clinical value,so it is worthy of popularization and application.

Key words： Clindamycin Gynecological Qianjin Tablets Chronic pelvic inflammatory disease Efficacy Safety

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Deng Ling-ling

Cite this article:

Deng Ling-ling. Clinical efficacy and safety analysis of Clindamycin combined with Gynecological Qianjin Tablets in the treatment of chronic pelvic inflammatory disease[J]. 中国当代医药, 2017, 24(35): 128-130.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I35/128

[1]	杨瑞.克林霉素联合千金胶囊对慢性盆腔炎性激素及炎症因子水平的影响[J].中国妇幼保健，2015，30（8）:1283-1285.
[2]	陈琪珍，田淑娜，陈雄.丹黄祛瘀胶囊联合克林霉素治疗慢性盆腔炎的临床研究[J].现代药物与临床，2017，32（5）:844-847.
[3]	黄修菊，伊丽达娜·米吉提，赵骏达，等.克林霉素联合氨曲南治疗盆腔炎性疾病的疗效及对炎性因子水平的影响[J].医学综述，2016，22（13）:2656-2659.
[4]	王敏，黄艳君.金刚藤联合妇科千金片对慢性盆腔炎的疗效及血清细胞因子的影响[J].中国妇幼健康研究，2015，26（4）:780-782.
[5]	Rui D，Fuhrich D，Ross JDC.A review of antibiotic therapy for pelvic inflammatory disease[J].Int J Antimicrob Ag，2015，46（3）:272-277.
[6]	李月芬，周繁荣.中西医结合治疗慢性盆腔炎的临床疗效分析[J].辽宁中医杂志，2015，58（2）:347-349.
[7]	王艳华.妇科千金片联合中药灌肠治疗慢性盆腔炎的疗效及对血液流变学和炎性因子水平的影响[J].河北医药，2015，44（20）:3076-3078.
[8]	黄春玉，邢秀月.中西医结合治疗慢性盆腔炎64例疗效观察[J].四川中医，2015，34（3）:126-128.
[9]	张小金，徐冬.妇科千金片联合阿莫西林克拉维酸钾片治疗慢性盆腔炎的临床疗效及安全性评价[J].辽宁中医杂志，2015，58（5）:1001-1002.
[10]	Haggerty CL，Totten PA，Tang G，et al.Identification of novel microbes associated with pelvic inflammatory disease and infertility[J].Sex Transm infect，2016，92（6）:441-446.
[11]	余学红，邱银峰.抗生素联合中成药治疗慢性盆腔炎的疗效观察[J].湖北中医药大学学报，2016，18（2）:72-73.
[12]	张福梅.金刚藤联合妇科千金片对慢性盆腔炎的疗效及其对患者血清细胞因子IL-6和GM-CSF水平的影响[J].中国妇幼保健，2016，31（13）:2606-2608.
[13]	朴香淑，孙艳茹，屈慧启，等.金刚藤联合妇科千金片治疗慢性盆腔炎的疗效及对血清细胞因子的影响[J].河北医药，2017，39（15）:2356-2358.
[14]	张晋峰，王军霞，李小栓，等.妇炎舒胶囊治疗湿热瘀结型慢性盆腔炎的有效性和安全性评价[J].西部中医药，2015，28（12）:8-11.
[15]	王霞，刘炜，腾威，等.妇科千金胶囊联合左氧氟沙星片治疗慢性盆腔炎疗效观察[J].陕西中医，2016，37（7）:790-791.